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Background
In order to address the complexities of Malignant
Hyperthermia (MH) and genetically related disorders it is
necessary to access and interrogate easily all information
collected over the last 40 years, in addition to incorporat-
ing the continuous supply of new information.
Material and methods
With all types of data held in a single database we are
interested in a number of projects including:
• A more detailed analysis of in vitro contracture test
(IVCT) data to better define phenotype for research
purposes, and to assess the effects of specific muta-
tions on the range of phenotypes. We have previously
conducted an analysis of the effects of a number of
ryanodine receptor type 1 (RYR1) mutations on IVCT
and MH reaction phenotypes.
• We have previously published preliminary work con-
sidering the possibility of genetic modifiers, and this is
a topical area with the role of common versus rare var-
iants as contributors to complex disorders being hotly
debated. It will be possible to initiate small projects on
the effects of previously identified single nucleotide
variants and SNV-SNV interactions on phenotype.
• To analyse observations such as discordancy in
greater depth.
• To assess the statistical power for large-scale stu-
dies such as a Genome Wide Association Scan.
Results
In Leeds, we have initiated a relational database, devel-
oped using FileMaker Pro®. This software was specifically
chosen due to its versatility to set permissions and access
rights ensuring that all data stored is kept secure.
A private, restricted access file, currently holds nearly
10,000 records, with one individual being represented as
one record. It contains names, family codes, date of birth
and diagnostic identification numbers. This file preserves
anonymity by assigning individuals within families a
unique identification number, subsequently acting to link
all other data. This private file is held on a different server
from the second wider access ‘public’ file, whose data is
linked to the private file only by the unique identifier. This
‘public’ file holds a range of information in the form of
tables:
• The family table describes familial relationships,
which will be suitable for exporting to .ped files,
enabling this data to be imported directly into
genetic analysis programs.
• The process table which holds sample collection
and storage information, together with the proce-
dures undertaken e.g. histology, exome sequencing,
preparation of myoblasts.
• The phenotype and IVCT tables contain information
such as clinical details and ‘raw’ IVCT data, allowing
for a more detailed analysis in addition to the clinical
definition of MHS versus MHN.
• The genotype table contains all genotypic informa-
tion to date such as mutation testing results.
Conclusions
We are interested in expanding this database by bringing
together Leeds data with other European data. We have
the ability to create accounts only for specified users and
management through privilege sets, ranging from full
access, data entry and read only. This would enable users
to assess the feasibility and initiate large-scale collabora-
tive programmes of research. Thus through use of this
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database, supported by the Leeds centre, we hope to
build collectively a pan European resource and interna-
tional virtual biobank.
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